Merida Group Hospice: The Money Was in Keeping Patients Enrolled

The Merida Group hospice fraud case exposed $150 million in false claims built on unqualified admissions, purchased physician certifications and fabricated records. The business brought patients in, bought the medical approval and made paperwork to keep the money coming. For a nurse who saw the patient, or an employee who saw the payments and instructions, those were parts of the same operation.

Merida operated a chain of hospice and home health agencies throughout Texas. The Justice Department’s account of the trial evidence described how the owner used marketing, kickbacks and false records to build the business. A jury convicted the owner and chief executive in November 2019.

How Merida Group Turned Hospice Admissions Into Revenue

Merida recruited patients by misrepresenting both their condition and what hospice was for. In its account of a manager’s role, the HHS Office of Inspector General described a conspiracy to convince thousands of people with long-term incurable diseases that they had less than six months to live, enrolling them in hospice programs for which they did not qualify.

The pitch could run in the opposite direction too. The Justice Department said trial evidence showed Merida marketed medical benefits as something “you don’t have to die to use.” In some instances, marketers falsely told patients they were close to death and sent chaplains who discussed last rites and preparations for dying. The same business sold the comfort of extra benefits and the fear of imminent death.

That pitch changed the patient’s health care coverage. A Medicare hospice election shifts payment for care related to the terminal illness to the hospice and generally waives payment to other providers for that care. The patient gives up other coverage for the illness while the provider collects for an enrollment the patient never qualified for.

The Owner’s Admission and Discharge Strategy

The owner’s control extended to keeping patients enrolled. Prosecutors described trial evidence that he directed staff against discharging patients, treating a discharge as interference with his money. Some patients were walking, driving, working and even coaching athletic events. Merida billed Medicare as though people coaching athletic events had months to live.

The hospice eligibility decision rests on a physician’s prognosis of six months or less if the illness runs its normal course. Continued benefits depend on continued eligibility and recertification. The admission assessment, the information sent to the physician and the later discharge decision therefore matter together. At Merida, the owner had a financial answer to a clinical question: keep the patient.

For an admissions nurse, the useful knowledge may be the assessment management overrode. For a clinical manager, it may be the instruction that kept a patient on service after staff recommended discharge. The person who saw that decision can explain why the patient remained on the billing rolls.

Why a Long Hospice Stay Was Valuable

Medicare pays routine hospice care by the enrolled day, including days when nobody visits. Costs tend to be higher around admission and death, with a less expensive stretch in between. A long stay can give a provider more of those lower-cost days. That is the financial setting in which pressure to admit and retain patients operates.

The HHS Office of Inspector General examined that incentive in its 2015 report, Medicare Hospices Have Financial Incentives to Provide Care in Assisted Living Facilities. In the report’s 2012 data, hospices received an average of $1,091 per week for a beneficiary receiving routine home care in assisted living and provided an average of 4.8 hours of visits. The payment also covered care beyond visits.

Merida’s case supplies the conduct: recruiting unqualified patients, paying for their certifications and resisting discharge. Understanding how an enrolled day becomes a Medicare claim connects those decisions to the revenue they protected.

The Chief Executive’s Control Over Clinical Records

Merida’s chief executive acted as its nursing director despite having no medical training. The government’s account of his conduct described a company-wide practice of falsifying medical records to conceal the scheme and pass insurance company audits.

The important control was over what the records said. A chart that appeared to support hospice care could reach a physician or an auditor carrying a version of the patient that management wanted them to see. The staff member who wrote the original assessment and the person who ordered it changed saw different stages of that process.

This is why the history of a clinical note can matter as much as its final wording. Earlier versions, instructions to change them and the underlying assessments can explain who shaped the account of the patient’s condition.

When Medical-Director Pay Bought the Certification

Merida made medical-director fees contingent on agreeing to certify unqualified hospice patients. One medical director also received luxury trips, bottle service at exclusive nightclubs and other perks in exchange for unnecessary certifications, according to the Justice Department’s account of the arrangement. He personally certified more than $18 million in unnecessary hospice services and pleaded guilty in June 2019.

The condition attached to the payment explains what Merida was buying. The physician’s signature supplied the clinical approval the business needed to bill. Payment depended on agreeing to approve patients who did not qualify. A medical-director title made the arrangement look like part of the clinical organization while the compensation bought the result.

The same connection between physician pay and patient volume appears in civil hospice referral kickback cases. In Tapestry Hospice’s settlement, the Department of Justice alleged that medical directors received monthly stipends and a signing bonus, with compensation rising when they referred more patients and falling when they failed to refer. Merida’s payment condition reached the certification itself. Both accounts put the compensation terms beside the patients the physician sent or approved.

An employee who handles physician payments may know that condition without ever seeing a patient. A clinician may know the patient never supported the certification without seeing the compensation arrangement. Bringing those accounts together can explain the transaction behind the signature.

What the Records Were Made to Hide

False records helped Merida pass insurance audits and later reached a federal grand jury. The owner and chief executive produced fabricated records to the grand jury and were convicted of conspiring to obstruct justice. The records served the same purpose at both stages: concealing how the business had obtained payment.

A parallel allegation in a SouthernCare whistleblower complaint shows how management pressure can enter the process before a chart even supports admission:

The allegation describes a decision to admit first and accept a substitute for medical support. Merida’s proven fabrication describes records made to conceal the business afterward. Both make the timing and source of the clinical information important. A finished chart alone can hide who asked for an admission, what information was available and what someone was told to change.

What Evidence Is Needed to Prove Fraud?

For a hospice scheme like Merida’s, the evidence connects the patient’s condition, the certification, the payments and the instructions behind the claim. A nurse’s earlier assessment can explain what changed in the chart. A medical-director agreement and payment history can explain what the physician was paid to approve. A discharge recommendation followed by continued billing can show the consequence of management’s decision.

An insider’s account gives those records their meaning.

The civil connection is concrete at Merida. In an April 7, 2022 announcement of a whistleblower lawsuit, the U.S. Attorney’s Office described a civil complaint against the owner and chief executive alleging false Medicare claims for medically unnecessary hospice and home health services. The civil allegations included medical-director kickbacks and fabricated patient records and certifications. The government pursued the decisions behind the claims as well as the claims themselves.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. We work with you to connect what you know about the patients, the payments and the people directing the business to build your strongest healthcare whistleblower case.

You Saw Who Made the Decision

If you saw patients kept on service, certifications bought or charts changed to satisfy an audit, bring that account to our whistleblower experts. We build the case with you and bring in hospice fraud whistleblower lawyers who understand clinical records and referral payments. You get an expert partner who stays beside you as the case moves from what you witnessed to the pursuit of a government recovery.